Effects of anti-CD70 mAb on Theiler's murine encephalomyelitis virus-induced demyelinaiting disease

Brain Research

Volumn 1317, Issue , 2010, Pages 236-245

  Yanagisawa, Satoshi ^a   Takeichi, Naoya ^a   Kaneyama, Tomoki ^b   Yagita, Hideo ^c   Taniguchi, Syun'ichiro ^a   Kim, Byung S ^d   Koh, Chang Sung ^a  

^a SHINSHU UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

CD70; Costimulatory molecules; Demyelinating disease; Multiple sclerosis; Theiler's murine encephalomyelitis virus

Indexed keywords

CD70 ANTIGEN; CD70 MONOCLONAL ANTIBODY; FR 70; GAMMA INTERFERON; IMMUNOGLOBULIN G; MESSENGER RNA; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATING DISEASE; DISEASE COURSE; FEMALE; GENE EXPRESSION; IN VIVO STUDY; MONONUCLEAR CELL; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; SPLEEN CELL; VIRUS PATHOGENESIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD70; CARDIOVIRUS INFECTIONS; CYTOKINES; DEMYELINATING DISEASES; FEMALE; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; MICE; RNA, MESSENGER; SPINAL CORD; SPLEEN; THEILOVIRUS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

MUS; THEILER'S ENCEPHALOMYELITIS VIRUS;

EID: 75849142830     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.12.058     Document Type: Article

References (58)

1. Akiba H., Miyahira Y., Atsuta M., Takeda K., Nohara C., Futagawa T., Matsuda H., Aoki T., Yagita H., and Okumura K. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis. J. Exp. Med. 191 (2000) 375-380
2. Allen I., and Brankin B. Pathogenesis of multiple sclerosis-the immune diathesis and the role of viruses. J. Neuropathol. Exp. Neurol. 52 (1993) 95-105
3. + T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice. J. Gen. Virol. 73 Pt 7 (1992) 1861-1865
4. Borst J., Hendriks J., and Xiao Y. CD27 and CD70 in T cell and B cell activation. Curr. Opin. Immunol. 17 (2005) 275-281
5. Bowman M.R., Crimmins M.A., Yetz-Aldape J., Kriz R., Kelleher K., and Herrmann S. The cloning of CD70 and its identification as the ligand for CD27. J. Immunol. 152 (1994) 1756-1761
6. Brahic M., Stroop W.G., and Baringer J.R. Theiler's virus persists in glial cells during demyelinating disease. Cell 26 (1981) 123-128
7. Cannons J.L., Lau P., Ghumman B., DeBenedette M.A., Yagita H., Okumura K., and Watts T.H. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. J Immunol. 167 (2001) 1313-1324
8. Clatch R.J., Lipton H.L., and Miller S.D. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. J. Immunol. 136 (1986) 920-927
9. Clatch R.J., Miller S.D., Metzner R., Dal Canto M.C., and Lipton H.L. Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology 176 (1990) 244-254
10. Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?. Nat. Rev., Immunol. 3 (2003) 609-620
11. Dal Canto M.C., and Lipton H.L. Primary demyelination in Theiler's virus infection. An ultrastructural study. Lab. Invest. 33 (1975) 626-637
12. Friedmann A., Frankel G., Lorch Y., and Steinman L. Monoclonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler's virus-infected mice: critical importance of timing of treatment. J. Virol. 61 (1987) 898-903
13. + T cell line specific for an immunodominant VP2 epitope. J. Immunol. 152 (1994) 919-929
14. + T cells in the periphery of patients with systemic lupus erythematosus. Lupus 14 (2005) 598-606
15. Hendriks J., Gravestein L.A., Tesselaar K., van Lier R.A., Schumacher T.N., and Borst J. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 1 (2000) 433-440
16. Hendriks J., Xiao Y., and Borst J. CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J. Exp. Med. 198 (2003) 1369-1380
17. Hintzen R.Q., Lens S.M., Beckmann M.P., Goodwin R.G., Lynch D., and van Lier R.A. Characterization of the human CD27 ligand, a novel member of the TNF gene family. J. Immunol. 152 (1994) 1762-1773
18. Hou W., Kang H.S., and Kim B.S. Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J. Exp. Med. 206 (2009) 313-328
19. Inoue A., Koh C.S., Yamazaki M., Yahikozawa H., Ichikawa M., Yagita H., and Kim B.S. Suppressive effect on Theiler's murine encephalomyelitis virus-induced demyelinating disease by the administration of anti-IL-12 antibody. J. Immunol. 161 (1998) 5586-5593
20. + T cell response to RNA polymerase in susceptible SJL/J mice. J. Virol. 83 (2009) 10981-10992
21. June C.H., Bluestone J.A., Nadler L.M., and Thompson C.B. The B7 and CD28 receptor families. Immunol. Today. 15 (1994) 321-331
22. Kappel C.A., Dal Canto M.C., Melvold R.W., and Kim B.S. Hierarchy of effects of the MHC and T cell receptor beta-chain genes in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Immunol. 147 (1991) 4322-4326
23. Karpus W.J., Pope J.G., Peterson J.D., Dal Canto M.C., and Miller S.D. Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction. J. Immunol. 155 (1995) 947-957
24. Kim B.S., Yauch R.L., Bahk Y.Y., Kang J.A., Dal Canto M.C., and Hall C.K. A spontaneous low-pathogenic variant of Theiler's virus contains an amino acid substitution within the predominant VP1(233-250) T-cell epitope. J. Virol. 72 (1998) 1020-1027
25. Kurtzke J.F., and Hyllested K. Multiple sclerosis in the Faroe Islands II clinical update, transmission, and the nature of MS. Neurology 36 (1986) 307-328
26. Lee W.W., Yang Z.Z., Li G., Weyand C.M., and Goronzy J.J. Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis. J. Immunol. 179 (2007) 2609-2615
27. Lehrich J.R., Arnason B.G., and Hochberg F.H. Demyelinative myelopathy in mice induced by the DA virus. J. Neurol. Sci. 29 (1976) 149-160
28. Lens S.M., Baars P.A., Hooibrink B., van Oers M.H., and van Lier R.A. Antigen-presenting cell-derived signals determine expression levels of CD70 on primed T cells. Immunology 90 (1997) 38-45
29. Lipton H.L., and Dal Canto M.C. Chronic neurologic disease in Theiler's virus infection of SJL/J mice. J. Neurol. Sci. 30 (1976) 201-207
30. Lipton H.L., Kratochvil J., Sethi P., and Dal Canto M.C. Theiler's virus antigen detected in mouse spinal cord 2 1/2 years after infection. Neurology 34 (1984) 1117-1119
31. Lipton H.L., Calenoff M., Bandyopadhyay P., Miller S.D., Dal Canto M.C., Gerety S., and Jensen K. The 5′ noncoding sequences from a less virulent Theiler's virus dramatically attenuate GDVII neurovirulence. J. Virol. 65 (1991) 4370-4377
32. Lipton H.L., Twaddle G., and Jelachich M.L. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Virol. 69 (1995) 2525-2533
33. Matter M., Odermatt B., Yagita H., Nuoffer J.M., and Ochsenbein A.F. Elimination of chronic viral infection by blocking CD27 signaling. J. Exp. Med. 203 (2006) 2145-2155
34. Miller S.D., Vanderlugt C.L., Begolka W.S., Pao W., Neville K.L., Yauch R.L., and Kim B.S. Epitope spreading leads to myelin-specific autoimmune responses in SJL mice chronically infected with Theiler's virus. J. Neurovirol. 3 Suppl. 1 (1997) S62-S65
35. Mueller D.L., Jenkins M.K., and Schwartz R.H. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7 (1989) 445-480
36. Mullen A.C., High F.A., Hutchins A.S., Lee H.W., Villarino A.V., Livingston D.M., Kung A.L., Cereb N., Yao T.P., Yang S.Y., and Reiner S.L. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292 (2001) 1907-1910
37. Myoung J., Bahk Y.Y., Kang H.S., Dal Canto M.C., and Kim B.S. Anticapsid immunity level, not viral persistence level, correlates with the progression of Theiler's virus-induced demyelinating disease in viral P1-transgenic mice. J. Virol. 82 (2008) 5606-5617
38. Nakajima A., Oshima H., Nohara C., Morimoto S., Yoshino S., Kobata T., Yagita H., and Okumura K. Involvement of CD70-CD27 interactions in the induction of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 109 (2000) 188-196
39. Nathanson N., and Miller A. Epidemiology of multiple sclerosis: critique of the evidence for a viral etiology. Am. J. Epidemiol. 107 (1978) 451-461
40. Nolte M.A., and van Lier R.A. The price of the CD27-CD70 costimulatory axis: you can't have it all. J. Exp. Med. 203 (2006) 2405-2408
41. Nolte M.A., van Olffen R.W., van Gisbergen K.P., and van Lier R.A. Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology. Immunol. Rev. 229 (2009) 216-231
42. Oshima H., Nakano H., Nohara C., Kobata T., Nakajima A., Jenkins N.A., Gilbert D.J., Copeland N.G., Muto T., Yagita H., and Okumura K. Characterization of murine CD70 by molecular cloning and mAb. Int. Immunol. 10 (1998) 517-526
43. Peterson J.D., Karpus W.J., Clatch R.J., and Miller S.D. Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus. Eur. J. Immunol. 23 (1993) 46-55
44. Pevear D.C., Calenoff M., Rozhon E., and Lipton H.L. Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses. J. Virol. 61 (1987) 1507-1516
45. Rodriguez M., Lafuse W.P., Leibowitz J., and David C.S. Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (Ia antigens). Neurology 36 (1986) 964-970
46. + cytotoxic T cell responses in vivo. J. Immunol. 172 (2004) 6039-6046
47. + T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo. J. Exp. Med. 204 (2007) 1095-1106
48. Song J., So T., Cheng M., Tang X., and Croft M. Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion. Immunity 22 (2005) 621-631
49. Tesselaar K., Gravestein L.A., van Schijndel G.M., Borst J., and van Lier R.A. Characterization of murine CD70, the ligand of the TNF receptor family member CD27. J. Immunol. 159 (1997) 4959-4965
50. Tesselaar K., Xiao Y., Arens R., van Schijndel G.M., Schuurhuis D.H., Mebius R.E., Borst J., and van Lier R.A. Expression of the murine CD27 ligand CD70 in vitro and in vivo. J. Immunol. 170 (2003) 33-40
51. + T cells for IL-12-induced Th1 cell development. Int. Immunol. 19 (2007) 713-718
52. Watts T.H. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23 (2005) 23-68
53. Wekerle H. Immunopathogenesis of multiple sclerosis. Acta. Neurol. (Napoli) . 13 (1991) 197-204
54. Welsh C.J., Tonks P., Nash A.A., and Blakemore W.F. The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice. J. Gen. Virol. 68 Pt. 6 (1987) 1659-1667
55. Williams I.R., and Unanue E.R. Costimulatory requirements of murine Th1 clones. The role of accessory cell-derived signals in responses to anti-CD3 antibody. J. Immunol. 145 (1990) 85-93
56. + T cell response after protein immunization. J. Immunol. 181 (2008) 1071-1082
57. + T cell-mediated alloimmune responses in vivo. J. Immunol. 174 (2005) 1357-1364
58. Yauch R.L., Palma J.P., Yahikozawa H., Koh C.S., and Kim B.S. Role of individual T-cell epitopes of Theiler's virus in the pathogenesis of demyelination correlates with the ability to induce a Th1 response. J. Virol. 72 (1998) 6169-6174